Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
about
Molecular interactions between Vestigial and Scalloped promote wing formation in DrosophilaCloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific mannerBoth a ubiquitous factor mTEF-1 and a distinct muscle-specific factor bind to the M-CAT motif of the myosin heavy chain beta geneThe TEAD Family and Its Oncogenic Role in Promoting TumorigenesisCharacterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domainPoly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcriptionGenomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs).Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle.Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprintingVariable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.Distinct TFIID complexes mediate the effect of different transcriptional activatorsTranscription enhancer factor-1 (TEF-1) DNA binding sites can specifically enhance gene expression at the beginning of mouse development.Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cyclePathogenesis of human papillomaviruses in differentiating epithelia.Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations.Association of human papillomavirus type 16 long control region mutation and cervical cancer.Identification and validation of human papillomavirus encoded microRNAsThe Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in DrosophilaDifferential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteriHuman papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses.YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world.Negative regulation of the vascular smooth muscle alpha-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins.Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.Characterization of a single strong tissue-specific enhancer downstream from the three human genes encoding placental lactogenNuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16Emerging roles of TEAD transcription factors and its coactivators in cancersGenetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expressionUpstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in cultureHuman papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.Flanking sequences modulate the cell specificity of M-CAT elements.A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.
P2860
Q22008588-A9BEEEE9-7A3C-4A33-BC1D-6B06248610CEQ24324627-F4FDE5D0-C721-46EF-B722-C5BF8ED3243CQ24632369-5EB9295E-13FD-4375-A85A-39D0369D8C53Q26775126-AF6BD6A2-9540-4B25-95D9-9B0622E734C2Q28263487-90495A9A-4C86-4E67-B36D-2C67C0C94C2BQ28272433-85768051-5A27-4493-87EA-945FC605F315Q28291892-BC2A8C4C-D522-402B-9482-363303503A13Q33498244-F2C78725-B63C-440D-A11B-24AA8726C43DQ33780601-D5EFB79A-BBD6-417F-B5F0-45260F7F941AQ33782147-9F3C41C2-082E-4037-843C-C8B0528E85FBQ33972393-197E5721-2C2E-44BD-BB0C-CA27908FC2C8Q34043048-4DCFC53B-37B4-4DDD-99FC-13E59B2E15D1Q34069639-614F3903-E28E-49A2-9FEA-F4D9F9035C92Q34338428-55B41102-3BF4-4128-B581-B310F7AB2A4FQ34349416-CAD5DA0F-FACF-4F2D-81E9-EB029F6ABC1BQ34390884-7F6F973D-75B6-41CF-A0B5-6C0758222FD7Q34559827-36631319-1EA8-4D19-9ACD-5C33E03C509CQ34922162-79BB04D5-0A4C-4BE6-95C7-3C9AB8FB09ACQ35211994-F42709D1-184E-4DA1-92C2-9473D6E841EBQ35782511-CC96B165-9EF8-4F91-9192-AAC1B0D10843Q35828061-A1083FB0-BDE2-4E82-B2AC-AC66AA6F7FB2Q35869296-6E67E52E-A83A-4C3E-B16C-4B03C43D8640Q35899069-850807AC-7CD4-4E3C-8A43-7A8816DB7E4FQ36523157-30551E78-C09D-4C1C-83D0-DF8958C1BF84Q36550763-97DA20B4-5EEE-4B91-ABA5-3D36C34AFF1BQ36627345-3594CCCB-1BF6-4A4A-94DD-A3192706EB8AQ36642807-CC53CCAB-36FD-441F-90F4-107DA58DEAE0Q36650759-11BB244F-BE7C-4105-9359-12A26548D5F6Q36901489-C007F37F-0D93-46BE-9F32-3022E06CA6DAQ36943163-052C77D8-F359-4EF5-BB3B-03A725D8AC83Q37093403-BA3D2799-5854-4851-A77C-F8BF4CD567EEQ37175161-CCEF69BA-B84B-4BAC-B1EC-1DB07C51BD17Q37256648-B11F46EA-AA56-4EB0-9C5A-FA6CC627BF9EQ37410680-EF382954-F42E-4BFE-A83B-29CBD28B8A46Q37659454-F3E1DD78-3BDC-4BD0-ACD7-3B9531E467D5Q38015671-A821B090-288B-4BE8-90AB-4B59B71B0B9EQ38293758-AE951264-67FB-45C3-A857-921DEEC9296EQ38314561-A45C62C3-3149-4A69-9EB0-A2AA818A080EQ38356143-5F5932B1-44C9-4B1F-9A69-F8053859C2C8Q39583285-92F2800E-2010-4173-A5B6-8C73E689A5D5
P2860
Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@ast
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@en
type
label
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@ast
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@en
prefLabel
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@ast
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@en
P2093
P2860
P1433
P1476
Transcriptional enhancer facto ...... and cervical carcinoma cells.
@en
P2093
I Davidson
R D Anderson
S Parkkinen
T H Haugen
P2860
P304
P407
P577
1992-06-01T00:00:00Z